The MicrobiomeDX team works with clinical trial investigators to deliver subject gut microbiome profile analysis and clinical implications in pursuit of the link between the microbiome and cancer immunotherapy response. We provide guidance on metadata collection, help design a testing timeline, and deliver phased lab reports to give you the most succinct, relevant view of your cohort to help achieve optimal outcomes and response rates.